Zepbound vs Mounjaro

A side-by-side comparison drawn from public information and community discussion.

Zepbound and Mounjaro are both brand names for tirzepatide from the same manufacturer. They share the same dual GIP/GLP-1 molecule and dosing ladder; the difference is the FDA-approved indication.

At a glance

Zepbound Mounjaro
Active ingredientTirzepatideTirzepatide
MechanismDual GIP / GLP-1 receptor agonistDual GIP / GLP-1 receptor agonist
FDA-approved useWeight management; obstructive sleep apneaType 2 diabetes
Dosing frequencyOnce weekly injectionOnce weekly injection
Dose range2.5 mg up to 15 mg2.5 mg up to 15 mg
Results discussionCommonly discussed for weight lossCommonly discussed for blood-sugar control and weight loss
Typical cost~$1,000–$1,300/mo list~$1,000–$1,100/mo list

Common questions

Are Zepbound and Mounjaro the same drug?

Yes — both are tirzepatide. They are marketed under different names for different FDA-approved uses (Zepbound for weight management and sleep apnea, Mounjaro for type 2 diabetes). Your prescriber and insurance often determine which one you receive.

Which one is better for weight loss?

They contain the same molecule, so the active drug is identical. Coverage, indication, and savings programs usually drive the choice. Discuss your goals with your prescriber.

Discuss it with the community

Compare experiences and ask questions: